Project Grant R21AI200574
- Federal Project Grant Award Summary Emory University received a $909,998 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective May 5, 2026 through April 30, 2031. The award supports research to develop an innovative HIV vaccination strategy utilizing DNA-lipid nanoparticle (DNA-LNP) technology designed to induce strong and durable cellular and humoral immune responses. The...
- Federal Project Grant Award Summary Emory University received a $909,998 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), with an award date of February 5, 2026, and a completion date of January 31, 2031. The research project focuses on characterizing antibody-mediated approaches to establish simian immunodeficiency virus (SIV) reservoirs without antiretroviral therapy (ART). The...
- Federal Grant Award Summary Emory University received a $2,297,892 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective July 17, 2025, with completion targeted for June 30, 2029. The award funds a four-year research investigation into the mechanisms by which interferon-induced transmembrane proteins (IFITMs) inhibit viral membrane fusion and restrict diverse enveloped viruses...
- Federal Project Grant Award Summary Emory University received a $234,156 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded on February 28, 2026, with a completion date of October 31, 2028. This research initiative addresses the capsid assembly mechanisms of Kaposi Sarcoma-Associated Herpesvirus (KSHV), a leading cause of cancer in HIV-positive individuals. The research will...
- Federal Grant Award Summary Emory University received a $160,448 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded on March 10, 2026, with a completion date of September 10, 2028. This research grant funds investigator-initiated biomedical research focused on understanding antiviral resistance mechanisms in orthopoxviruses, specifically addressing the emergence of drug...
- Federal Grant Award Summary Emory University received a $500,500 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) for research titled "Immunometabolism of Myeloid Suppressor Cell Responses to M. Tuberculosis in People With HIV." The award, dated June 8, 2026, with a completion date of May 31, 2028, supports investigator-initiated biomedical research examining the immunological...
- Federal Grant Award Summary Emory University received a $160,546.00 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective September 3, 2025, through August 31, 2029. The project, titled "Towards Foundation Epidemic Models for Respiratory Infections: A Novel Spatiotemporal Machine Learning Framework," will be conducted at Emory's Atlanta, Georgia campus. This award...
- Federal Grant Award Summary Emory University received a $711,555 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective May 13, 2025, through April 30, 2030. The project delivers an integrated research and development framework combining graph neural networks with traditional compartmental models to advance understanding of spatiotemporal transmission dynamics and control...
- Federal Grant Award Summary Emory University received a $941,106 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective July 7, 2025, through June 30, 2027. The award supports research into the genetic regulation of Factor VIII (FVIII) inhibitor development in hemophilia A patients. The project will utilize Diversity Outbred (DO) mouse models—an outbred population derived from...
- Federal Grant Award Summary Emory University received a $412,749 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period of February 6, 2026 through January 31, 2028. The grant supports research focused on identifying and characterizing cis-regulatory elements (enhancers) that can facilitate precise genetic manipulation of specific B-cell subsets. The research addresses a critical...
Emory University received a $430,375 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective June 12, 2026, with a completion date of May 31, 2028. The research project investigates the regulation of human immunodeficiency virus type 1 (HIV-1) fusion competence through examination of spacer peptide 2 (SP2) and matrix protein structural maturation. The study employs an interdisciplinary approach combining quantitative investigation of SP2's effects on viral membrane properties and fusion mechanisms to advance understanding of HIV-1 infectivity and fusion dynamics. The funded research will deliver scientific knowledge regarding SP2's role in HIV-1 membrane modulation and fusion competence through structured investigation via two specific aims. Preliminary data suggest that SP2 binding to synthetic and plasma membrane-derived liposomes increases membrane lipid order and membrane tension, supporting the hypothesis that SP2 functions as a membrane modulator independent of matrix protein presence. The project outcomes will contribute to the broader scientific understanding of HIV-1 viral maturation mechanisms and fusion biology, potentially informing future therapeutic development in infectious disease research.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $430.4k | 6/16/26 |